Trials / Unknown
UnknownNCT05608226
Impact of Health Lifestyle on Body Weight
Impact of Health Lifestyle on Body Weight Post Cessation of Pharmacotherapy in Obese Subjects
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 190 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Pharmacotherapy becomes an important and effective approach to improve body weight. However, it still remains unclear how to manage potential fluctuation after its cessation. Lifestyle change is the foundation and included as a part of clinical routine in real-world, therefore, we plan to conduct a prospective observational study to assess the impact of health lifestyle along with its compliance on body weight in Chinese people who live with obesity or overweight and are off-pharmacotherapy trial. The aim of this study is to examine the impact of health lifestyle along with its compliance on body weight related parameters in 6 months at 3 monthly intervals from treatment. In addition, body weight related results will be described.
Detailed description
Novel pharmacotherapy is emerging, leading to substantial and sustained improvement in body weight compared with placebo in clinical trials. However, there is no evidence on management of body weight in real world setting after cessation of treatment. Body weight fluctuation is a pivotal difficulty for obese subjects who left off pharmacotherapy. It would be interesting to investigate the impact of real-world health lifestyle and its compliance in this clinical situation and probe into factors affecting compliance. Therefore, we will conduct a prospective observational study to assess the impact of health lifestyle along with its compliance on body weight in Chinese people who live with obesity or overweight and are off-pharmacotherapy trial. The aim of this study is to examine the impact of health lifestyle along with its compliance on body weight related parameters in 6 months at 3 monthly intervals from pharmacotherapy cessation. In addition, body weight related results will be described.
Conditions
Timeline
- Start date
- 2022-09-15
- Primary completion
- 2023-06-30
- Completion
- 2023-09-30
- First posted
- 2022-11-08
- Last updated
- 2022-11-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05608226. Inclusion in this directory is not an endorsement.